Vanguard Global Advisers »

Nuvectis Pharma shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $45k 5.8k 7.73

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Nuvectis Pharma

Vanguard Group
BlackRock
Vanguard Capital Management
Iridian Asset Management
Occam Crest Management
Geode Capital Management
Baldwin Brothers
Susquehanna International
State Street Corporation
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management
Citadel Advisors
Oppenheimer & Co
Paul Kendrigan

View all funds holding Nuvectis Pharma